The Lynx Group

Conference Correspondent

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

Conference Correspondent — December 21, 2020
Utilization management tools and prior authorization are associated with delays in care for patients and high costs for physicians. In this session, panelists discuss the impact on cancer care, with an eye toward providing appropriate care while minimizing administrative burden.
Read Article

Conference Correspondent — December 18, 2020
With more than 1.8 million diagnoses of cancer per year in the United States, identifying malignancies at the earliest stage is priority among physicians. In this session, experts discuss the future of early-stage cancer diagnosis and how to improve cancer screenings.
Read Article

Conference Correspondent — December 17, 2020
Oncology nurse and patient navigators are playing an ever-increasing role in supporting patients with cancer and their caregivers. In this session, experts discuss the standardized measures and processes used by oncology nurse and patient navigators.
Read Article

Conference Correspondent — December 16, 2020
In this session, experts discuss the challenges faced at the beginning of the COVID-19 pandemic, how they worked to overcome them, and what lessons they will take with them into the future.
Read Article

Conference Correspondent — December 15, 2020
Specialized oncology pharmacy programs are playing an ever-increasing role in the complex delivery of care. In this session, panelists discuss the obstacles and successes of specialized oncology pharmacy programs.
Read Article

Conference Correspondent — December 11, 2020
In this session, a panel of experts share the Wall Street perspective on the opportunities and challenges ahead for cancer drug developers and healthcare providers.
Read Article

Conference Correspondent — December 9, 2020
Healthcare continues to adapt to the economic impact of the COVID-19 pandemic. In this session, industry experts discuss the underlying trends and economic realities of cancer care in the United States and global markets.
Read Article

Conference Correspondent — December 8, 2020
The increased complexity of new oncology drugs and the accelerated rate of their approval has led to greater demands from stakeholders across the cancer care continuum. In this session, panelists discuss oncology drug supply chain channels and how they are incorporated in the move to value-based care.
Read Article

Conference Correspondent — December 4, 2020
Numerous new innovations in stem-cell transplantation are coming to the market. In this session, experts offer the clinician, manufacturer, and payer perspectives regarding these new therapies.
Read Article

Conference Correspondent — December 3, 2020
As one of the largest operational oncology value-based payment models, OCM has been a driving force in cancer
Read Article

Page 1 of 41

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: